GPS Wealth Strategies Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
GPS Wealth Strategies Group's PFE Position: Q4 2025 in Review
GPS Wealth Strategies Group reduced its Pfizer (PFE) stake by 73% in Q4 2025, selling an estimated $229K and leaving 3,357 shares worth $83.6K. The position accounts for 0.07% of the portfolio, ranked #166.
GPS Wealth Strategies Group first reported a position in PFE in Q3 2020 and has held it in 22 quarters since. The position peaked at $967K in Q4 2021. 2,905 funds tracked by Wall St. Rank hold PFE as of Q4 2025.
- GPS Wealth Strategies Group held 3,357 shares of Pfizer worth $83.6K as of Q4 2025.
- GPS Wealth Strategies Group sold 9,098 Pfizer shares in Q4 2025, an estimated $229K.
- Pfizer made up 0.07% of GPS Wealth Strategies Group's portfolio in Q4 2025, its #166 holding.
- GPS Wealth Strategies Group first reported a position in Pfizer in Q3 2020 and has held it in 22 quarters since.
- GPS Wealth Strategies Group's Pfizer position peaked at $967K in Q4 2021.
- 2,905 funds tracked by Wall St. Rank held Pfizer as of Q4 2025.
Based on GPS Wealth Strategies Group's 13F filing for Q4 2025, filed 6 Feb 2026.